These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27116691)

  • 1. Testicular seminoma clinical stage 1: treatment outcome on a routine care level.
    Dieckmann KP; Dralle-Filiz I; Matthies C; Heinzelbecker J; Bedke J; Ellinger J; Anheuser P; Souchon R; Pichlmeier U;
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1599-607. PubMed ID: 27116691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
    Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
    World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
    Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
    J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
    Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
    J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surveillance of stage I testicular seminoma: 20 years oncological results].
    Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
    Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).
    Tandstad T; Ståhl O; Dahl O; Haugnes HS; Håkansson U; Karlsdottir Å; Kjellman A; Langberg CW; Laurell A; Oldenburg J; Solberg A; Söderström K; Stierner U; Cavallin-Ståhl E; Wahlqvist R; Wall N; Cohn-Cedermark G;
    Ann Oncol; 2016 Jul; 27(7):1299-304. PubMed ID: 27052649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seminoma Clinical Stage 1 - Patterns of Care in Germany.
    Dieckmann KP; Dralle-Filiz I; Heinzelbecker J; Matthies C; Bedke J; Ellinger J; Sommer J; Haben B; Souchon R; Anheuser P; Pichlmeier U
    Urol Int; 2016; 96(4):390-8. PubMed ID: 27092560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
    Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
    J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.
    Tyldesley S; Voduc D; McKenzie M; Duncan G; Liu M; Wu D
    Urology; 2006 Mar; 67(3):594-8. PubMed ID: 16527585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cycles of adjuvant carboplatin for clinical stage 1 testicular seminoma in New Zealand centres: A retrospective analysis of efficacy and long-term events.
    Chandran EA; Chindewere A; North R; Jameson MB
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1310. PubMed ID: 33103860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma.
    Aparicio J; García del Muro X; Maroto P; Paz-Ares L; Alba E; Sáenz A; Terrasa J; Barnadas A; Almenar D; Arranz JA; Sánchez M; Fernández A; Sastre J; Carles J; Dorca J; Gumà J; Yuste AL; Germà JR;
    Ann Oncol; 2003 Jun; 14(6):867-72. PubMed ID: 12796024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study.
    Aparicio J; Sánchez-Muñoz A; Gumà J; Domenech M; Meana JA; García-Sánchez J; Bastús R; Gironés R; González-Billalabeitia E; Sagastibelza N; Ochenduszko S; Sánchez A; Terrasa J; Germà-Lluch JR; García Del Muro X;
    Oncology; 2018; 95(1):8-12. PubMed ID: 29587278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients.
    Kamba T; Kamoto T; Okubo K; Teramukai S; Kakehi Y; Matsuda T; Ogawa O
    Int J Urol; 2010 Dec; 17(12):980-7. PubMed ID: 20955354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance in stage I testicular seminoma - risk of late relapse.
    Chung P; Parker C; Panzarella T; Gospodarowicz MK; Jewett S; Milosevic MF; Catton CN; Bayley AJ; Tew-George B; Moore M; Sturgeon JF; Warde P
    Can J Urol; 2002 Oct; 9(5):1637-40. PubMed ID: 12431325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.
    Fischer S; Tandstad T; Wheater M; Porfiri E; Fléchon A; Aparicio J; Klingbiel D; Skrbinc B; Basso U; Shamash J; Lorch A; Dieckmann KP; Cohn-Cedermark G; Ståhl O; Chau C; Arriola E; Marti K; Hutton P; Laguerre B; Maroto P; Beyer J; Gillessen S
    J Clin Oncol; 2017 Jan; 35(2):194-200. PubMed ID: 27893332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?
    Dieckmann KP; Brüggeboes B; Pichlmeier U; Küster J; Müllerleile U; Bartels H
    Urology; 2000 Jan; 55(1):102-6. PubMed ID: 10654903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up.
    Mead GM; Fossa SD; Oliver RT; Joffe JK; Huddart RA; Roberts JT; Pollock P; Gabe R; Stenning SP;
    J Natl Cancer Inst; 2011 Feb; 103(3):241-9. PubMed ID: 21212385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.